Mcl-1 levels critically impact the sensitivities of human colorectal cancer cells to APG-1252-M1, a novel Bcl-2/Bcl-X(L) dual inhibitor that induces Bax-dependent apoptosis

New treatment options, such as targeted therapies, are urgently needed for the treatment of colorectal cancer (CRC), the third leading cause of cancer-related deaths worldwide. The current study focuses on demonstrating the therapeutic efficacies of APG-1252-M1 (an active form of the prodrug, APG-12...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Weilong, Bai, Longchuan, Wang, Shaomeng, Zha, Yifan, Sun, Shi-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046866/
https://www.ncbi.nlm.nih.gov/pubmed/35462114
http://dx.doi.org/10.1016/j.neo.2022.100798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046866/
https://www.ncbi.nlm.nih.gov/pubmed/35462114
http://dx.doi.org/10.1016/j.neo.2022.100798

Ejemplares similares